Concepedia

Publication | Open Access

Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303

DOIFull Paper Access

73

Citations

9

References

2019

Year

Xiaoyan Si, Li Zhang, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang,
Thoracic Cancer

Abstract

Anlotinb-related adverse events could be controlled by patient education, prophylactic measures, early and active intervention, and dose modification.

References

YearCitations

Page 1